Lactovit Deodorant Antiperspirant Invisible
Aluminum Zirconium Octachlorohydrex Gly
Ac Marca Personal Care, S.l.
Human Otc Drug
NDC 42283-043Lactovit Deodorant Antiperspirant Invisible also known as Aluminum Zirconium Octachlorohydrex Gly is a human otc drug labeled by 'Ac Marca Personal Care, S.l.'. National Drug Code (NDC) number for Lactovit Deodorant Antiperspirant Invisible is 42283-043. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Lactovit Deodorant Antiperspirant Invisible drug includes Aluminum Zirconium Octachlorohydrex Gly - 100 mg/mL . The currest status of Lactovit Deodorant Antiperspirant Invisible drug is Active.
Drug Information:
| Drug NDC: | 42283-043 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Lactovit Deodorant Antiperspirant Invisible |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Aluminum Zirconium Octachlorohydrex Gly |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Ac Marca Personal Care, S.l. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY - 100 mg/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Jul, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 16 Jan, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part350 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | AC MARCA PERSONAL CARE, S.L.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | P9D3YP29MY
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 42283-043-00 | 50 mL in 1 BOTTLE, WITH APPLICATOR (42283-043-00) | 01 Jul, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose antiperspirant
Product Elements:
Lactovit deodorant antiperspirant invisible aluminum zirconium octachlorohydrex gly water steareth-2 ppg-15 stearyl ether glycine steareth-21 butylene glycol xanthan gum calcium lactate sodium lactate .alpha.-tocopherol acetate tocopherol niacinamide allantoin propanediol cyclomethicone 5 sunflower oil edetate disodium anhydrous phenoxyethanol aluminum zirconium octachlorohydrex gly aluminum zirconium octachlorohydrex gly
Indications and Usage:
Uses reduces underarm wetness.
Warnings:
Warning for external use only. do not use on broken skin. in case of accidental ingestion seek professional assistance or contact a poison control center immediately. keep away from face and mouth. ask a doctor or pharmacists before use if you have kidney disease. stop use and ask a doctor if rash or irritation occurs. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
Do Not Use:
Warning for external use only. do not use on broken skin. in case of accidental ingestion seek professional assistance or contact a poison control center immediately. keep away from face and mouth. ask a doctor or pharmacists before use if you have kidney disease. stop use and ask a doctor if rash or irritation occurs. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
Dosage and Administration:
Directions apply to underarms only.
Stop Use:
Stop use and ask a doctor if rash or irritation occurs.
Package Label Principal Display Panel:
Package labeling label4
Further Questions:
Questions or comments: + 1-787-780-4043